Company Profile
Area of Focus:
Device
Stage:
Market
Contact Info:
BiOptix, Inc.
1745 38th Street, Suite A
Boulder CO 80301
Tel: 303.545.5550
Fax: 303.545.5551
Email:
bioptix@bioptix.com
Web:
http://www.bioptix.com/index.php
BiOptix Inc
BiOptix Inc has developed a highly-sensitive biosensor for detection of trace amounts (~pg/mm2) of bacteria, viruses, proteins, nucleic acids, antibodies and other biological and chemical agents in real-time and with minimal human intervention. Recently, BiOptix scientists used the prototype biosensor to detect clinically significant levels of human micro RNAs in experimental samples, opening an avenue for early and robust diagnostics of a variety of cancers. The unique patented biosensor design relies upon the common path interferometric detection principle in combination with non-resonant surface plasmon excitation. This design was conceived by BiOptix Chief Scientific Adviser, Dr. John Hall, 2005 Physics Nobel Prize Laureate. A number of novel engineering decisions, described in the Technology section of our website, set BiOptix's biosensor far apart from the competition. The new instrument has attracted significant interest from the US military, medical diagnostic industry, and pharmaceutical companies. Our R&D efforts are backed by funding from a group of highly experienced technology investors and multiple SBIR grants.